US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SANUWAVE Health, Inc.

36.24

-2.2300-5.80%

Post-market: 36.240.00000.00%16:10 EDT

Volume:49.62K

Turnover:1.82M

Market Cap:310.55M

PE:-6.49

High:38.51

Open:38.51

Low:35.49

Close:38.47

Loading ...

Overview Company News Filings

SANUWAVE Health Inc. Announces Separation Agreement with Former Chief Commercial Officer, Including Cash Payment and Stock Option Vesting

SANUWAVE Health Initiated at Buy by Roth Capital

Sanuwave Health Inc : Roth Mkm Initiates Coverage With Buy Rating; Target Price $49

THOMSON REUTERS

Roth Capital Initiates Sanuwave Health at Buy With $49 Price Target

MT Newswires Live

Sanuwave Health (SNWV) Has a New Rating from Roth MKM

SANUWAVE Health Inc. to Present at 45th Annual Canaccord Genuity Growth Conference

Sanuwave Health Preliminary Q2 Revenue Meets Guidance

MT Newswires Live

SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024

Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares

Sanuwave Health Inc. Appoints Industry Veteran Dustin Libby as Executive VP of Commercial Operations

SANUWAVE Health Inc. Files Initial Beneficial Ownership Statement for Director Gregory Matthew Bazar

SANUWAVE Health Inc. Joins Russell 2000® Index

SANUWAVE Health Inc. Appoints Greg Bazar to Board of Directors as Michael Stolarski Steps Down

Iulian Cioanta, Chief Scientific and Technology Officer, Reports Disposal of Common Shares in SANUWAVE Health Inc

SANUWAVE Health Inc. Changes Auditors Amid Internal Control Weaknesses

SANUWAVE Health Q1 EPS $(0.66) Up From $(1.46) YoY, Sales $9.34M Up From $5.79M YoY

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025

Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

Sanuwave Health Shares Rise on 2025 Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SNWV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNWV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","market":"US","secType":"STK","nameCN":"SANUWAVE Health, Inc.","latestPrice":36.24,"timestamp":1754078400000,"preClose":38.47,"halted":0,"volume":49624,"hourTrading":{"tag":"盘后","latestPrice":36.24,"preClose":36.24,"latestTime":"16:10 EDT","volume":319,"amount":11560.56,"timestamp":1754079003996},"delay":0,"floatShares":4926742,"shares":8569338,"eps":-5.582863,"marketStatus":"Market Closed","change":-2.23,"latestTime":"08-01 16:00:00 EDT","open":38.51,"high":38.51,"low":35.49,"amount":1815051.9714,"amplitude":0.078503,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.582863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":38.47,"preHourTrading":{"tag":"盘前","latestPrice":38.47,"preClose":38.47,"latestTime":"09:18 EDT","volume":231,"amount":8908.470648,"timestamp":1754054305933},"postHourTrading":{"tag":"盘后","latestPrice":36.24,"preClose":36.24,"latestTime":"16:10 EDT","volume":319,"amount":11560.56,"timestamp":1754079003996},"volumeRatio":1.3210028440474615},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","floatShares":4926742,"roa":"17.20%","roe":"196.48%","lyrEps":-7.029536,"volumeRatio":1.3210028440474615,"shares":8569338,"dividePrice":0,"high":38.51,"amplitude":0.078503,"preClose":38.47,"low":35.49,"week52Low":5.2118,"pbRate":"-17.96","psRate":"8.58","week52High":39.83,"institutionHeld":0,"latestPrice":36.24,"eps":-5.582863,"divideRate":0,"volume":49624,"delay":0,"ttmEps":-5.582863,"open":38.51,"prevYearClose":23,"prevWeekClose":37.86,"prevMonthClose":38.47,"prevQuarterClose":32.86,"fiveDayClose":37.86,"twentyDayClose":31.65,"sixtyDayClose":30.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNWV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556385616","title":"SANUWAVE Health Inc. Announces Separation Agreement with Former Chief Commercial Officer, Including Cash Payment and Stock Option Vesting","url":"https://stock-news.laohu8.com/highlight/detail?id=2556385616","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556385616?lang=en_us&edition=fundamental","pubTime":"2025-08-01 04:41","pubTimestamp":1753994489,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. Announces Separation Agreement with Former Chief Commercial Officer, Including Cash Payment and Stock Option Vesting. SANUWAVE Health Inc. has announced a new compensation agreement following the termination of Nanci Gilmore, the company's former Chief Commercial Officer. As part of a Separation and Release Agreement dated July 28, 2025, Ms. Gilmore will receive a lump sum cash payment totaling $112,707.51, which includes five months' annual base salary and a pro-rated bonus. Additionally, her employee stock options will continue to vest through January 31, 2026, and remain exercisable until their expiration dates. The agreement also includes standard confidentiality and non-disparagement clauses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDLbF6Kkp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2555634890","title":"SANUWAVE Health Initiated at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2555634890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555634890?lang=en_us&edition=fundamental","pubTime":"2025-07-30 01:02","pubTimestamp":1753808520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNWV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 29, 2025 13:02 ET (17:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2555624059","title":"Sanuwave Health Inc : Roth Mkm Initiates Coverage With Buy Rating; Target Price $49","url":"https://stock-news.laohu8.com/highlight/detail?id=2555624059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555624059?lang=en_us&edition=fundamental","pubTime":"2025-07-29 20:31","pubTimestamp":1753792301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nFWN3TQ18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2555496053","title":"Roth Capital Initiates Sanuwave Health at Buy With $49 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2555496053","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555496053?lang=en_us&edition=fundamental","pubTime":"2025-07-29 19:23","pubTimestamp":1753788199,"startTime":"0","endTime":"0","summary":"Roth Capital Initiates Sanuwave Health at Buy With $49 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNWV"],"gpt_icon":0},{"id":"2555208141","title":"Sanuwave Health (SNWV) Has a New Rating from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2555208141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555208141?lang=en_us&edition=fundamental","pubTime":"2025-07-29 12:35","pubTimestamp":1753763725,"startTime":"0","endTime":"0","summary":"In a report released today, Kyle Bauser from Roth MKM initiated coverage with a Buy rating on Sanuwave Health and a price target of $49.00. The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sanuwave-health-snwv-has-a-new-rating-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sanuwave-health-snwv-has-a-new-rating-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNWV"],"gpt_icon":0},{"id":"2553126326","title":"SANUWAVE Health Inc. to Present at 45th Annual Canaccord Genuity Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2553126326","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553126326?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:05","pubTimestamp":1753214728,"startTime":"0","endTime":"0","summary":"Sanuwave Health, Inc.  announced that its CEO, Morgan Frank, will present at the 45th Annual Canaccord Genuity Growth Conference, taking place on August 12-13, 2025, at the InterContinental Hotel in Boston, Massachusetts. The presentation is scheduled for August 13 from 9:30 to 9:55 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL7lqyDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4082","IE00BKPKM429.USD","BK4585","NDAQ","IE00BGHQF748.EUR","SNWV","LU2095319765.USD","BK4588","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2551136806","title":"Sanuwave Health Preliminary Q2 Revenue Meets Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2551136806","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551136806?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:56","pubTimestamp":1752526590,"startTime":"0","endTime":"0","summary":"Sanuwave Health (SNWV) said preliminary Q2 revenue of $10.1 million to $10.2 million was in line with guidance announced May 9.Revenue rose 41% to 42% from a year earlier, the company said Monday in a statement.Sanuwave expects to release full Q2 around Aug. 8.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNWV"],"gpt_icon":0},{"id":"2551135797","title":"SANUWAVE Health Inc. Reports Record Q2 2025 Revenue, Up 41-42% from Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135797","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135797?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:30","pubTimestamp":1752525030,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has announced preliminary revenue results for the second quarter of 2025, indicating a range of $10.1 million to $10.2 million. This marks the highest Q2 quarterly revenues in the company's history and represents a significant increase of 41% to 42% compared to the same period in 2024. Additionally, the first half of 2025 saw revenue growth of 50-51% compared to the first half of 2024. The company attributes this revenue growth to a period of significant transition, including the addition of a new head of sales and a new head of commercial operations. SANUWAVE has rapidly expanded its sales force, reaching 13 salespeople and covering all national sales territories for the first time under CEO Morgan Frank's leadership. A key national accounts manager, dubbed the \"elephant hunter,\" has also been added to target larger market opportunities. The company plans to release its full Q2 results on or around August 8, 2025, providing a more comprehensive update on its perfo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL3yDwM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","NDAQ"],"gpt_icon":0},{"id":"2542563263","title":"Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542563263","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542563263?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:51","pubTimestamp":1749513072,"startTime":"0","endTime":"0","summary":"Peter Stegagno, Chief Operating Officer of SANUWAVE Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL4NCvLF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2540769487","title":"Sanuwave Health Inc. Appoints Industry Veteran Dustin Libby as Executive VP of Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769487","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769487?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:30","pubTimestamp":1748950245,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has appointed Dustin Libby as the new Executive Vice President of Commercial Operations. Libby, who started on June 3, 2025, brings 20 years of experience in medical devices, with a focus on commercial growth and sales operations. His previous roles include leadership positions at Abiomed, Smith & Nephew, Arthrex, and Hill-ROM. Libby holds a B.S. degree in Product Design & Development from Keene State College.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL1gHPLs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU1732800096.USD","LU1778281490.HKD","LU1032466523.USD","LU1023059063.AUD","LU0203345920.USD","IE0034235303.USD","LU2112291526.USD","LU2602419157.SGD","LU1280957306.USD","IE00BGHQF748.EUR","LU0098860793.USD","LU0058720904.USD","IE00B2B36J28.USD","LU1914381329.SGD","LU2430703251.USD","LU0345770308.USD","LU0795875086.SGD","LU1674673691.USD","IE00B19Z3581.USD","IE00B1BXHZ80.USD","LU1074936037.SGD","NDAQ","LU0289739699.SGD","IE00B42XCP33.USD","BK4592","LU1244550577.SGD","IE00BVYPNW00.USD","BK4532","IE0002141913.USD","LU1066053197.SGD","LU2129689431.USD","LU0882574055.USD","IE00B3PB1722.GBP","LU1894683348.USD","BK4007","BK4588","IE00BDGV0183.EUR","LU0345769631.USD","JNJ","SG9999002224.SGD","IE00BBT3K403.USD","SNWV","LU1061106388.HKD","LU1221951129.SGD","IE00BKPKM429.USD","IE00BLSP4452.SGD","LU2129689514.USD","IE00BFTCPJ56.SGD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2539295481","title":"SANUWAVE Health Inc. Files Initial Beneficial Ownership Statement for Director Gregory Matthew Bazar","url":"https://stock-news.laohu8.com/highlight/detail?id=2539295481","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539295481?lang=en_us&edition=fundamental","pubTime":"2025-05-30 04:26","pubTimestamp":1748550369,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Gregory Matthew Bazar as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL2dbt7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2539098774","title":"SANUWAVE Health Inc. Joins Russell 2000® Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2539098774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539098774?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:10","pubTimestamp":1748463010,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. is going to be added to the Russell 2000 Index as part of the 2025 Russell indexes reconstitution. This inclusion is based on the company's market-capitalization ranking, as the annual reconstitution process captures the 4,000 largest U.S. stocks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDLb9C3Zg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SNWV","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4082","LU2210149790.SGD","BK4112","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2539067274","title":"SANUWAVE Health Inc. Appoints Greg Bazar to Board of Directors as Michael Stolarski Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2539067274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539067274?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:05","pubTimestamp":1748462733,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has appointed Greg Bazar to its Board of Directors, effective May 27, 2025. Bazar brings extensive experience in engineering, technology, and cybersecurity. Concurrently, long-time board member Michael Stolarski will be stepping down but will continue as a consultant to assist in the transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL58M1ts:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","NDAQ"],"gpt_icon":0},{"id":"2536323689","title":"Iulian Cioanta, Chief Scientific and Technology Officer, Reports Disposal of Common Shares in SANUWAVE Health Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2536323689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536323689?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:49","pubTimestamp":1747428542,"startTime":"0","endTime":"0","summary":"Iulian Cioanta, Chief Scientific and Technology Officer of SANUWAVE Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDLQYPDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2535870289","title":"SANUWAVE Health Inc. Changes Auditors Amid Internal Control Weaknesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2535870289","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535870289?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:17","pubTimestamp":1747340225,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc., a Nevada corporation, announced a change in its independent registered public accounting firm, transitioning from CBIZ CPAs P.C. to Baker Tilly US, LLP, effective for the fiscal year ending December 31, 2025. The decision, approved by the company's Audit Committee, comes after identifying material weaknesses in internal controls over financial reporting. These weaknesses include a lack of internal controls over key accounting and IT processes, insufficient expertise to apply U.S. GAAP to complex transactions, and inadequate resources for financial instrument accounting in service agreements. The transition aims to address these issues and enhance the company's financial reporting standards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL4K9SY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2534162365","title":"SANUWAVE Health Q1 EPS $(0.66) Up From $(1.46) YoY, Sales $9.34M Up From $5.79M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2534162365","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534162365?lang=en_us&edition=fundamental","pubTime":"2025-05-09 04:47","pubTimestamp":1746737231,"startTime":"0","endTime":"0","summary":"SANUWAVE Health (OTC:SNWV) reported quarterly losses of $(0.66) per share. This is a 54.79 percent increase over losses of $(1.46) per share from the same period last year.  The company reported $9.34 million in sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45302153/sanuwave-health-q1-eps-0-66-up-from-1-46-yoy-sales-9-34m-up-from-5-79m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2533056502","title":"Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533056502","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533056502?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478800,"startTime":"0","endTime":"0","summary":"EDEN PRAIRIE, Minn., May 05, 2025  -- Sanuwave Health, Inc.  , a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM  to present its Q1 2025 financial results.Telephone access to the call will be available by dialing the following numbers:. Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanuwave-host-conference-call-may-210000136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","BK4561","BK4590","BK4218","BK4588","BK4585","SNWV","HST","BK4581","BK4181","ET","AM","BK4082"],"gpt_icon":0},{"id":"2525481846","title":"Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525481846","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525481846?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:45","pubTimestamp":1744119934,"startTime":"0","endTime":"0","summary":"April 8 (Reuters) - SANUWAVE Health Inc ::*SANUWAVE HEALTH ANNOUNCES PRELIMINARY REVENUE RESULTS FOR THE FIRST QUARTER 2025 (ENDED MARCH 31, 2025)*SANUWAVE HEALTH : DOES NOT ANTICIPATE ANY SIGNIFICANT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nRSD4SpDml:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","SNWVD"],"gpt_icon":0},{"id":"2525891216","title":"Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891216?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115400,"startTime":"0","endTime":"0","summary":"SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history.Q1 2025 revenue increased between 57% and 61% compared to Q1 2024.UltraMIST revenues for Q1 2025 increased by more than 65% versus Q1 2024 and accounted for approximately 99% of the Company's total revenues.\"Sanuwave is pleased to announce a strong start to 2025, putting up our best Q1 in Company history,\" said CEO Morgan Frank. \"Q1 was a transition quarter as we moved to a new head of sales and restructured the sales force. I'm very proud of the team managing this without missing a beat. Our pipeline remains robust and consistent with 2025 being a breakout year for Sanuwave. The Company plans to release its full Q1 results on or around May 9, 2025 and we look forward to speaking with you then to give you a more complete update on our quarterly performance and our future plans and guidance.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2521557202","title":"Sanuwave Health Shares Rise on 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2521557202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521557202?lang=en_us&edition=fundamental","pubTime":"2025-03-22 03:05","pubTimestamp":1742583900,"startTime":"0","endTime":"0","summary":"Shares of Sanuwave Health climbed on the path toward their highest close in almost three years after the company guided for further growth in 2025.The stock gained 13%, to $36.20, in Friday afternoon trading. Shares are up 57% year to date.The developer of patented noninvasive, biological response activating devices said it expects revenue of $48 million to $50 million for 2025 as it guided for a first-quarter top-line performance between $8.4 million and $9 million.In 2024, the company had reported revenue of $32.6 million.\"We are confident that our revenue pipeline is stronger than it has ever been and have been ramping up our sales force and sales strategy to meet this opportunity and to effectively manage the larger customers with whom we continue to engage,\" Chief Executive Morgan Frank said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNWV\",params:#limit:5,,,undefined,":[{"date":"2025-07-14","symbol":"SNWV","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1752523200000,"name":null,"time":"Post Market","dateTimestamp":1752465600000,"actualEps":null},{"market":"US","date":"2025-05-09","symbol":"SNWV","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.66},{"date":"2025-04-08","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1744099200000,"name":null,"time":"Pre-Market","dateTimestamp":1744084800000,"actualEps":null},{"date":"2025-03-21","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1742544000000,"name":null,"time":"Pre-Market","dateTimestamp":1742529600000,"actualEps":null},{"market":"US","date":"2024-11-08","symbol":"SNWV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNWV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNWV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1754020800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNWV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNWV","date":"2025-08-01","current":-10.137221,"percent":0.178218,"low":-702.038129,"twenty":-9.973066,"median":-8.489263,"eighty":-7.866852,"high":-6.892901,"avg":-78.115382,"sd":200.547693,"marketCap":329662432},"quantilePoints":[{"date":"2025-03-07","current":-691.068781,"twenty":-691.068781,"median":-691.068781,"eighty":-691.068781,"marketCap":268825756},{"date":"2025-03-14","current":-618.012938,"twenty":-636.222054,"median":-618.342019,"eighty":-603.314015,"marketCap":240407033},{"date":"2025-03-21","current":-702.038129,"twenty":-696.553455,"median":-636.222054,"eighty":-618.012938,"marketCap":273092832},{"date":"2025-03-28","current":-10.158328,"twenty":-695.675907,"median":-618.342019,"eighty":-10.354519,"marketCap":318687073},{"date":"2025-04-04","current":-8.120123,"twenty":-691.068781,"median":-601.668614,"eighty":-10.158328,"marketCap":254744495},{"date":"2025-04-11","current":-7.981154,"twenty":-636.222054,"median":-10.315009,"eighty":-8.485256,"marketCap":250384774},{"date":"2025-04-17","current":-7.964805,"twenty":-631.834315,"median":-10.235987,"eighty":-8.284706,"marketCap":249871865},{"date":"2025-04-25","current":-8.106499,"twenty":-621.084356,"median":-9.959412,"eighty":-8.117398,"marketCap":254317071},{"date":"2025-05-02","current":-7.937556,"twenty":-618.14457,"median":-8.840852,"eighty":-7.959355,"marketCap":249017018},{"date":"2025-05-09","current":-8.596976,"twenty":-606.2538,"median":-8.485256,"eighty":-7.977884,"marketCap":269704323},{"date":"2025-05-16","current":-8.230402,"twenty":-601.997694,"median":-8.460732,"eighty":-7.977884,"marketCap":267652689},{"date":"2025-05-23","current":-7.589004,"twenty":-128.772111,"median":-8.419859,"eighty":-7.932511,"marketCap":246794415},{"date":"2025-05-30","current":-7.413815,"twenty":-10.431905,"median":-8.357187,"eighty":-7.77174,"marketCap":241097258},{"date":"2025-06-06","current":-7.313841,"twenty":-10.307106,"median":-8.265183,"eighty":-7.613389,"marketCap":237846124},{"date":"2025-06-13","current":-8.153092,"twenty":-10.259149,"median":-8.223668,"eighty":-7.613389,"marketCap":265138539},{"date":"2025-06-20","current":-8.681898,"twenty":-10.238439,"median":-8.201487,"eighty":-7.680874,"marketCap":282335328},{"date":"2025-06-27","current":-8.692422,"twenty":-10.197566,"median":-8.241733,"eighty":-7.758805,"marketCap":282677552},{"date":"2025-07-03","current":-8.32673,"twenty":-10.118545,"median":-8.276515,"eighty":-7.76153,"marketCap":270785246},{"date":"2025-07-11","current":-9.452745,"twenty":-9.895105,"median":-8.32673,"eighty":-7.767839,"marketCap":307403282},{"date":"2025-07-18","current":-9.860536,"twenty":-9.816004,"median":-8.376261,"eighty":-7.783254,"marketCap":320664627},{"date":"2025-07-25","current":-9.686619,"twenty":-9.939637,"median":-8.436208,"eighty":-7.823705,"marketCap":315008864},{"date":"2025-08-01","current":-10.137221,"twenty":-9.973066,"median":-8.489263,"eighty":-7.866852,"marketCap":329662432}],"updateTime":1754126921057}}}